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ABSTRACT 
 
Aim: The aim of this study was to evaluate the hepatoprotective and antioxidant activities of 
Ferulago angulata Extract (FAE) in experimental diabetic rats. 
Materials and Methods: 54 adult male Wistar rats divided into 6 groups (n=9). Diabetes was 
induced in all animals except those in group 1 by the daily intraperitoneal injection of 120 mg/kg 
Original Research Article 
  
 
 
Mousavi-Ezmareh et al.; EJMP, 20(2): 1-9, 2017; Article no.EJMP.35134 
 
 
 
2 
 
alloxan monohydrate for 3 consecutive days. Experimental diabetic rats in groups 3-5 were orally 
administered with FAE (200,400, and 800 mg/kg/day, respectively). Group 6 was treated with 150 
mg/kg of metformin. At the end of week 4, the rats were anesthetized and then sacrificed by 
cardiac puncture. Then, the levels of liver markers, malondialdehyde (MDA), and antioxidant 
enzymes capacity were evaluated in each group. 
Results: Treatment with FAE resulted in a significant reduction in aspartate transaminase (AST) 
and alanine transaminase (ALT) activities as well as in the serum and liver tissue contents of MDA 
in comparison to the diabetic control group (P<0.001). The FAE-treated diabetic rats showed a 
significant increase in catalase, glutathione peroxidase (GPx), and super oxide dismutase (SOD) 
activities of the liver (P-values were dose-dependent). Furthermore, the extract has an ameliorative 
effect on the histopathological changes of the liver in alloxan induced diabetes. 
Conclusions: These findings suggest that FAE can reduce the complications of diabetes, prevent 
oxidative stress, and improve antioxidant status in diabetic rats. 
 
 
Keywords: Ferulago angulata; antioxidant; oxidative stress; diabetes mellitus. 
 
1. INTRODUCTION 
 
Diabetes Mellitus (DM), a major worldwide health 
problem, is a chronic metabolic disease that is 
characterized by increased concentration of 
glucose in the blood, resulting from the defects in 
insulin secretion, insulin action, or both [1,2]. It 
has been found that diabetes-induced 
hyperglycemia can cause various structural and 
metabolic problems in many body organs such 
as kidney, muscle, nerve, etc. [3].  
 
One of the major complications of diabetes is its 
effect on the liver and hepatocytes [4,5]. In liver, 
diabetes can lead to glycogen deposition, 
steatosis and nonalcoholic steatohepatitis 
(NASH), fibrosis and cirrhosis, biliary disease, 
cholelithiasis, cholecystitis, and other related 
complications [6]. There has been extensive 
research regarding the liver disease occurring as 
a consequence of diabetes mellitus. For 
example, Wild et al. showed that type 2 DM is 
related to the increased risk associated with 
different types of liver diseases [7] and 
Hazlehurst et al. demonstrated that non-alcoholic 
fatty liver disease (NAFLD) is prevalent among 
up to 70% of the patients with diabetes [8]. 
Several experimental studies suggest that 
increased production of reactive oxygen species 
(ROS) in diabetes plays an important role in the 
onset of hyperglycemia-related liver damage [9]. 
However, antidiabetic medications are now used 
for the treatment of diabetic patients many of 
which are incapable of treating the complications 
caused by diabetes such as liver disease. 
Furthermore, due to the serious adverse effects 
of synthetic drugs, using these medications for 
long periods of time has now been limited [10]. 
Therefore, medicinal plants which have 
traditionally been used for herbal remedies are 
now used for the treatment of many diseases 
and illnesses. 
 
Ferulago angulata (Schlecht) Boiss., belongs to 
the Apiaceae, is a medicinal plant of West Asia, 
which contains essential oils and has many 
therapeutic uses in traditional medicine [11]. The 
phenolic and flavonoids compounds of Ferulago 
angulata extract (FAE) exhibit antioxidant, 
antimicrobial and anti-cancer properties [12,13]. 
The lipid-lowering effects and lipid peroxidation-
decreasing properties of this plant have been 
shown [10]. 
 
In the previous study, we showed the beneficial 
effects of FAE on lipid profile and blood sugar 
[14]. However, we could not find any studies on 
the hepatoprotective and antioxidants effects of 
FAE in experimental diabetes mellitus. 
Therefore, in the present study, we aimed                  
to evaluate the liver enzymes and               
antioxidant effects of FAE in alloxan-induced 
diabetic rats. 
 
2. MATERIALS AND METHODS 
 
2.1 Animals 
 
Healthy adult male Wistar albino rats with an 
average weight of 200-250 g were purchased 
from Pasture Institute, Tehran, Iran and  housed 
in standard and clean cages (2 per cage) under 
controlled environmental conditions at room 
temperature of 22 ± 3°C and in a 12:12 light–
dark cycle with free access to a standard rat 
chow and clean water [5]. The animal 
experiments ethics committee approved the 
study (Approval number 
IR.ARUMS.REC.1394.129). 
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2.2 Diabetes Induction  
 
Diabetes was induced in rats by the 
intraperitoneal (i.p.) injection of fresh solution of 
alloxan monohydrate (Sigma Ltd., USA) (120 
mg/kg) for 3 days [15]. Elevated glucose level 
(>300 mg/dl) in the blood from the tail vein 
(OKmeter Match, Taiwan) on days 3 and 7 after 
the injection of alloxan was taken as the 
confirmation of diabetes [16]. Normal rats were 
injected with an equal volume of vehicle (sodium 
citrate buffer). 
 
2.3 Preparation of Plant Extract 
  
The plant samples were collected at the humidity 
level of 45-60% in May and June from Shahr-e 
Kord, the capital of Chaharmahal and Bakhtiari 
Province, Iran. The whole plant of FAE was 
shade-dried at room temperature and powdered 
in a Wiley mill. Fifty grams of powdered herb was 
solved in 200 ml of equal volume (1:1) of water 
and methanol for 72 hours at 15°C to 20°C. The 
extract was filtered and placed in a vacuumed 
rotary evaporator solvent [17]. Then, it was 
incubated at the temperature of 40°C for 2 days. 
The lyophilized powder was stored in a dry and 
cold place. Then, appropriate amounts of the 
lyophilized extract were weighed and orally 
gavaged to each rat according to their weekly 
body weights for 4 weeks on a daily basis. 
 
2.4 Experimental Groups and Treatment 
 
Control and diabetic animals were divided into 6 
groups of at least 9 animals each and treated by 
an appropriate regimen for 4 weeks as follows: 
 
Group I  : Normal control rats. 
Group II  : Diabetic control. 
Group III  : Diabetic rats treated with 
hydroalcoholic extract of the whole  
plant of FAE (200 mg/kg). 
Group IV : Diabetic rats treated with  
hydroalcoholic extract of the whole 
plant of FAE (400 mg/kg). 
Group V : Diabetic rats treated with 
hydroalcoholic extract of the whole 
plant of FAE (800 mg/kg). 
Group VI : Diabetic rats treated with metformin 
(150 mg/kg). 
 
Rats in group I and II received normal rat 
regimen. Groups III-V treated with 200, 400, and 
800 mg/kg hydroalcoholic extract of FAE 
respectively. In group VI, the standard anti-
hyperglycemic drug (metformin) was 
administered once daily through oral gavage for 
28 consecutive days. 
 
After the last treatment, rats were fasted for 12 h 
and then anesthetized with chloroform. Blood 
samples were taken from all the experimental 
animals by heart puncture and the collected 
samples were allowed to clot for 30 min and 
centrifuged at 3000 RPM for 10 min to obtain 
serum in order to estimate the biochemical 
parameters. Slices of livers obtained from each 
animal were washed with isotonic saline solution 
and homogenized. Then, aliquots were 
immediately frozen in liquid nitrogen and stored 
at −80°C until the measurement of parameters 
such as catalase, superoxide dismutase (SOD), 
glutathione peroxidase (GPx) activities, and 
malondialdehyde (MDA) concentration. 
 
2.5 Phytochemical Screening 
 
The hydroalcoholic extract of FAE was analyzed 
for the presence of phenolic compounds and 
total flavonoids. Phenolic compounds was 
quantified using Folin-Ciocalteau’s assay [18] 
with some differences. The assay mixture was 
made with 100 µl of sample, 0.5 ml of 10% Folin-
Ciocalteau’s reagent, and 0.4 ml of sodium 
bicarbonate 7.5% solution. Gallic acid was used 
as the standard in the concentrations of 0.25, 50, 
75, 100, and 125 PPM in methanol 60% solution. 
The absorbance was measured 
spectrophotometrically against a blank at 725 nm 
after the incubation of assay mixture for 30 min. 
 
Total flavonoids measurement of flavonoid 
concentration in hydroalcoholic extract of FAE 
was done based on the method described by 
Dowd using the aluminum chloride colorimetric 
protocol [19]. A 0.5 ml extract was mixed with 
methanol (1.5 ml), to which 2% aluminum 
chloride (1 ml), 5% potassium acetate (6 ml), and 
deionized water (2.8 ml) were added. The 
solution was vortexed and allowed to sit for 40 
minutes at room temperature. After that, the 
absorbance was measured at 415 nm using a 
spectrophotometer. The total flavonoid content 
was quantified according to the standard curve 
prepared with gallic acid and the concentrations 
of flavonoids were reported as mg per gram of 
extract.  
 
2.6 Determination of Biochemical 
Parameters 
 
The liver biomarkers (AST and ALT) were 
analyzed using an auto-analyzer (BT 3000, Italy) 
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by commercially available kits from Pars Azmoon 
(Pars Azmoon Inc., Tehran, Iran). 
 
2.7 Determination of Lipid Peroxides in 
Plasma and Liver 
 
MDA (as a lipid peroxidation marker) level in 
serum and liver homogenate was measured as 
described previously by Agarwal et al. [20] using 
a reverse phase high-pressure liquid 
chromatography (HPLC) (Agilent 1100 Series 
HPLC system) after derivatization with 2, 4-
dinitrophenylhydrazine were purchased from 
Merck, Germany. 
 
2.8 Assay of Catalase 
 
Catalase was assayed according to the method 
described previously by Hugo Aebi [21]. The 
assessment was done spectrophotometrically 
following the decrease in absorbance at 240 nm. 
1 g of the liver tissue was homogenized in 50 
mM phosphate buffer (pH 7.0) at the temperature 
of 4°C and then centrifuged at 4500 RPM. The 
reaction mixture contained 0.01 M phosphate 
buffer (pH 7.0), 2 mM Hydrogen peroxide (Merck, 
Germany), and the enzyme extract. The specific 
activity of catalase was expressed in terms of 
unit/mg protein. 
 
2.9 Assay of Superoxide Dismutase 
(SOD)  
 
The specific activity of superoxide dismutase in 
liver homogenate was determined by the method 
proposed by Sun et al. [22]. The principle of the 
method is based on the inhibition of nitroblue 
tetrazolium (NBT) (Sigma) reduction by the 
xanthine/XO system as a superoxide generator. 
In so doing, 250 mg of tissue was homogenized 
in 4 ml Tris buffer (50 mM Tris, 225 mM sucrose, 
1 mM EDTA, PH=74) 0.8 ml of assay reagent 
(containing 0.3 mM xanthine, 0.6 mM Na2EDTA 
(All chemical were purchased from Merck), 0.15 
mM nitroblue tetrazolium (NBT), and 0.4 M 
(Na2CO3) (Merck,) was mixed with 100 µl of liver 
homogenate and 100 µl Xanthine oxidase. 
Spectrophotometric absorbance was measured 
at 560 nm. Activity was expressed as unit/mg 
protein. 
 
2.10 Assay of Glutathione Peroxidase 
(GPx)  
 
To assay the GPx, 250 mg of tissue was 
homogenized in 4 ml Tris buffer (50 mM Tris, 225 
mM sucrose, 1 mM EDTA, PH=74). 100 µl of 
tissue homogenate was mixed with 750 µl assay 
buffer (171 mM potassium phosphate buffer, 
4.28 mM sodium azide, 2.14 mM EDTA, 6 mM 
reduced glutathione, and 0.9 mM NADPH) and 5 
µl of glutathione reductase 2 U/mL. The reaction 
started with the addition of 150 µl of 0.72 mM 
H2O2. The absorbance was measured by 
spectrophotometer at 340 nm [23]. 
 
2.11 Histomorphological Studies 
 
Some pieces of liver tissue were fixed in 40 g/L 
buffered formaldehyde, dehydrated with alcohol, 
embedded in paraffin, cut into 4-5 µm thick 
sections, and stained with hematoxylin and eosin 
(H&E) for general histopathological examinations 
according to a described procedure [24]. 
 
2.12 Statistical Analysis 
 
Data were analyzed statistically using SPSS 
Software, Version 20 and the results were 
expressed as mean ± SEM. One-way analysis of 
variance (ANOVA) was used to compare 
different groups and determine overall effect of 
each treatment with the confidence level of 95% 
(p<0.05) considered to be significant. 
 
3. RESULTS 
 
3.1 Body Weight  
 
No significant differences were observed in the 
weight of the healthy and diabetic control animals 
after 28 days. Furthermore, no significant 
difference was observed after treatment with 
FAE or metformin as compared to the diabetic 
control group. 
 
3.2 Blood Glucose 
 
As showed in the previous study [14], there was 
a significant increase in blood glucose (P< 0.001) 
in diabetic rats as compared with those in normal 
control group. Administration of FAE extract at 
200 mg, 400 mg, 800 mg, and metformin 
decreased blood glucose in diabetic rats by 26% 
(P<0.01), 59.3% (P<0.001), 69.4% (P<0.001), 
and 28.8% (P<0.01), respectively. 
 
3.3 Toxicity Study 
 
A toxicity study revealed the non-toxic 
characteristics of the extract. The rats treated 
with different doses of FAE did not show any 
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drug-induced physical symptoms of toxicity 
during the whole experimental period and no 
deaths were reported. 
 
3.4 Liver Enzymes 
 
Induction of diabetes caused a significant 
increase (p< 0.001) in the activities of AST and 
ALT as compared to the corresponding control 
animals. Serum activities of AST of diabetic rats 
significantly decreased (P<0.01 for FAE (200 
mg) and P<0.001 for both FAE (400 mg) and 
FAE (800 mg) after 28 days of treatment. 
Administration of FAE with the doses of 400 mg 
and 800 mg significantly decreased ALT activity 
(P<0.05 and P<0.01, respectively) as compared 
to the un-treated diabetic group (Table 1). 
Treatment with metformin (150 mg/kg) did not 
show significant decrease in the activity of     
AST and ALT compared to the diabetic control 
group. 
 
Table 1.  Comparison of measured liver 
markers between the experimental groups 
 
              Parameters 
Group 
AST 
(IU/ml) 
ALT 
(IU/ml) 
Normal  11.38+5.6 57+2.5 
Diabetic control 69.8+4.7a♣ 112.2+7.9a♣ 
Diabetic + FAE  
(200 mg)  
33+7.5b♠ 91.6+3.5 
Diabetic + FAE  
(400 mg) 
5.4+3.1b♣ 80.8+3.2b* 
Diabetic + FAE  
(800 mg) 
7.8+5.4b♣ 63.6+3.6b♠ 
Diabetic + metformin 56.6+5.02 97.8+9.6 
AST: Aspartate transaminase, ALT: Alanine 
transaminase, a; Compared to normal group, b; 
Compared to diabetic control group, *; P<0.05, ♠; 
P<0.01, ♣; P<0.001. Values are given as mean + 
S.E.M for 9 rats in each group. A P-value of less than 
0.05 was considered as statistically significant. 
 
3.5 Antioxidant Enzymes 
 
As presented in Table 2, there is a significant 
decrease in the level of catalase (P<0.01), SOD, 
and GPx (P<0.001 for both) in the diabetic group 
compared with the healthy group. Administration 
of FAE (400 mg) increased catalase, SOD, and 
GPx significantly (P<0.01 for catalase and CAT 
and P<0.001 for GPx). Treating with FAE (800 
mg) also increased these three enzymes 
significantly by P<0.001. Treatment                        
with metformin did not change catalase,  
however it increased SOD and GPx activity 
(P<0.01). 
3.6 Oxidative Stress Marker 
 
Concentrations of serum MDA (s-MDA) and 
tissue MDA (t-MDA) increased in alloxan-induced 
diabetic rats compared with the healthy control 
group. Administration of FAE extract for 28 days 
decreased s-MDA (P<0.001) and t-MDA 
(P<0.01) significantly as compared with the 
diabetic control group. Also, in the group treated 
with metformin, s-MDA and t-MDA decreased 
significantly (P<0.05 and P<0.01, respectively 
(Table 2). 
 
3.7 Antioxidant Compounds in Extract 
 
The amounts of total phenol, flavonoid, and 
flavonol were 13, 42, and 4 mg in one gram of 
hydroalcoholic extract of FAE, respectively.  
 
3.8 Liver Histology 
 
The central vein, hepatocyte, and portal space 
were observed to be normal in the normal control 
group (Fig. 1-A). The damage to the liver cells in 
the form of damaged central vein, hepatocytes, 
and portal trial could be seen clearly in the 
alloxan-induced diabetic rats (Fig. 1-B). These 
damages were reversed in the FAE treated 
groups (Fig. 1-C, D, and E). It seems that the 
amelioration effect of FAE on liver cells is dose-
dependent. The therapeutic effect of metformin is 
shown in (Fig. 1-F). 
 
4. DISCUSSION 
 
There are numerous studies and clinical 
evidences showing that the production of high 
levels of oxygen free radicals increases in Type 1 
diabetes and that the onset of diabetes is closely 
related to the level of oxidative stress [25,26]. 
The diabetogenic substance of alloxan 
monohydrate has three different pathological 
effects that intervene in the physiological function 
of pancreatic beta cells. First, alloxan selectively 
inhibits glucose-induced insulin secretion through 
its capability to specifically inhibit glucokinase, 
the glucose sensor of the beta cell. Second, 
alloxan is a urea derivative which causes a state 
of insulin-dependent diabetes mellitus through its 
ability to induce a selective necrosis of the beta 
cells. Third, alloxan-induced beta-cell toxicity is 
mediated by the formation of oxygen free 
radicals such as superoxide. These three effects 
of alloxan can be assigned to its specific 
chemical properties that cause islet beta cell 
destruction and increase plasma glucose [27-29]. 
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Table 2.  Comparison of measured antioxidant enzyme activity and lipid peroxidation marker 
between the experimental groups 
 
Group CAT 
(U/mg 
protein) 
SOD 
(U/mg 
protein) 
GPx 
(U/mg 
protein) 
s-MDA 
(µM) 
t-MDA 
(µM) 
Normal  327.5+14 27.5+1 88.9+5.8 1.4+0.1 1.3+0.1 
Diabetic control 215+20a♠ 14.3+0.8a♣ 43.2+3.8a♣ 7.9+0.4a♣ 7.9+0.4a♣ 
Diabetic + FAE (200 mg)  232.8+20 20.4+2.4 46.2+5.3 2.5+0.2b♣ 5.0+0.1b♠ 
Diabetic + FAE (400 mg) 341.6+16b♠ 23.8+1.9b♠ 87+4.2b♣ 2.8+0.2b♣ 5.1+0.3b♠ 
Diabetic + FAE (800 mg) 369.1+27b♣ 27.4+0.8b♣ 86+5.0b♣ 2.4+0.1b♣ 4.6+0.2b♠ 
Diabetic + metformin 288.4+15 23+1.6b♠ 74+6.8b♠ 6.8+0.2b* 5.0+0.3b♠ 
CAT: Catalase, SOD: Superoxide dismutase, GPx: Glutathione peroxidase, sMDA: Serum Malondialdehyde, 
tMDA: Tissue Malondialdehyde. a; Compared to normal group, b; Compared to diabetic control group, *; P<0.05, 
♠; P<0.01, ♣; P<0.001. Values are given as mean + S.E.M for 9 rats in each group. A P-value of less than 0.05 
was considered as statistically significant. 
 
 
 
Fig. 1. Effects of Ferulago angulate extract (FAE) on hepatic morphological analysis (paraffin-
embedded sections were stained with hematoxylin and eosin (H&E)). (A) Control group with no 
noticeable histological changes, (B) Alloxan-induced diabetic control group showing severe 
histopathological changes and necrosis, (C) Diabetic + FAE(200 mg/kg), (D) Diabetic + FAE(400 
mg/kg), (C) Diabetic + FAE(800 mg/kg), and metformin (150 mg/kg). Rats treated with 800 
mg/kg dose showed more improvement than those treated with 400 mg/kg and 200 mg/kg 
doses so its therapeutic effects are dose dependent (Original magnification, ×400) 
 
Injury to the liver in diabetes, which can be 
induced by alloxan, releases and also increases 
the level of liver enzymes in the bloodstream 
[30]. The significant dose-dependent reduction in 
the serum levels of these enzymes after the 
administration of FAE indicates its anti-
hepatotoxic effect in diabetes which may have 
been brought about by the stability of plasma 
membrane as well as the repair of tissue 
damage.  
The results of our study indicated that                           
the plant extract administered to the diabetic 
animals during 28 days reduced liver and serum 
MDA concentrations (P<0.001). It has been 
revealed that in hyperglycemia, antioxidant 
defenses change due to the presence                            
of diabetic conditions leading to the increase                   
in free radical production [31,32]. FAE 
significantly inhibited the increase of serum and 
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liver MDA levels and indicated a protective effect 
against oxidative stress.  
 
Antioxidant scavenger systems deficiency under 
diabetic conditions can increase lipid 
peroxidation due to oxidative stress [33,34]. The 
results of our study showed that catalase, SOD, 
and GPx activities were significantly lower in the 
diabetic animals compared to the healthy ones 
(P<0.01 for catalase and P<0.001 for two 
others). After 28 days, treatment with FAE 
significantly increased the activity of these 
enzymes (P values were dose dependent and 
was not significant in FAE 200 mg/kg). These 
effects might be related to the antioxidant activity 
of the extract. The increase in the activity of 
enzymatic antioxidants may be helpful in 
reversing the action of the alloxan           
monohydrate through the antioxidant mechanism 
[35]. 
 
In this study, we observed some lesions in the 
livers of diabetic animals including structural 
changes in hepatocytes, both sinusoids and 
portal areas, and enlargement of sinusoids. The 
same results were reported by Mahmoud and Al-
Salahy who demonstrated in their study that 
alloxan-induced hyperglycemia plays a crucial 
role in the genesis of liver injury [36]. The 
structural abnormalities and degenerative 
changes induced by alloxan monohydrate in the 
livers of diabetic rats ameliorated by the 
administration of FAE and metformin. This effect 
was more prominent at the dose of 800 mg/kg 
FAE. The presence of phenolic compounds and 
flavonoids in our extract might be the reason           
for its antioxidant and thus liver treating activity 
[37]. 
 
5. CONCLUSION 
 
The present investigation suggested that 
hydroalcoholic extract of FAE exerts an anti-
hepatotoxic effect via inhibiting oxidative stress 
due to the presence of phenolic and flavonoid 
compounds and their anti-oxidant nature. 
However, further investigations are needed to 
elucidate the precise molecular mechanism of 
specific bio-active agents of FAE for the 
protection against, and treatment of, the diabetes 
induced by alloxan or other toxic agents and 
validate these findings.  
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